Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Dashboard Provides "Real-Time" Views of Pathology Lab Data

By LabMedica International staff writers
Posted on 22 Jul 2015
A new software addition to an anatomic pathology platform provides lab managers a quick and reliable, at-a-glance view of operational data, enabling to better monitor progress, anticipate bottlenecks, and avoid potential problems.

"Having the ability to monitor operational efficiency in real-time is crucial to a lab's success in today's time-pressed anatomic pathology environment," said Rick Callahan of NovoPath, Inc. More...
(Princeton, NJ, USA), "Typically, labs deal with problems after they negatively impact efficiency. With the NovoPath Dashboard, the lab manager can proactively monitor the pulse of the lab and make needed adjustments to eliminate bottlenecks and maximize efficiency." It presents critical statistical information in an easy-to-read graph or chart format for visual overview.

NovoPath is an anatomic pathology laboratory information management software platform that acts as a data warehouse for pathology cases and offers solutions for reporting, image acquisition, label printing, electronic signoff, synoptic reporting, voice dictation, billing, outreach, and more. It is designed for use at independent pathology practices and for easy integration with an existing Hospital Management System (HMS). It helps streamline workflows in a variety of settings, from general hospital to specialized reference labs, and supports adaptation to changing lab regulations. The platform is scaled to fit lab size, from multi-site, multi-facility labs examining thousands of cases per day to single-site labs.

"NovoPath is designed based on a deep understanding of anatomic pathology workflow and offers a broad range of flexible features," said Mr. Callahan, adding that deployment of such modules will help a lab succeed in a changing environment.

Related Links:

NovoPath



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.